Proposed new USP Chapter <1095> Batch Release Testing for Ensuring Compliance with Uniformity of Dosage Units
Recommendation
Tuesday, 14 January 2025 13.00 - 17.30 h
In the Pharmacopeial Forum, PF 47(4), a proposal of a new USP Chapter <1095> Batch Release Testing for Ensuring Compliance with Uniformity of Dosage Units, addressing the common use of Uniformity of Dosage Units <905> as a batch release test, has been published for comments.
A Chapter numbered below 1000 becomes applicable and compendially required respect where it is referenced in a monograph or another applicable General Chapter numbered below 1000 or in General Notices. General Chapters numbered 1000 to 1999 are for informational purposes only. They are considered interpretive and are intended to provide information on, give definition to, or describe a particular subject.
According to the USP, the new proposed "chapter presents an approach to testing for content uniformity that is focused on ensuring that an item in commerce will meet the requirements of <905> utilizing appropriate quality risk management principles."
The chapter is divided into the following sections:
- Introduction
- Basic Principles
- Parametric Batch Release
- References
The draft of the proposed new chapter <1095> Batch Release Testing for Ensuring Compliance with Uniformity of Dosage Units is available following this link. (Please note: a one-time registration is required to access the Pharmacopeial Forum.) The deadline for submitting comments is September 30, 2021.
Related GMP News
11.12.2024Another FDA Warning Letter Based on Review of Records
04.12.2024FDA Warning Letter to South African OTC Drug Manufacturer
02.12.2024How to keep Analytical Systems Current and Compliant
27.11.2024FDA Inspections in the EU: Warning Letter to Italian OTC Drug Manufacturer
21.11.2024New GMP Journal Article on Analytical Instrument Qualification and System Validation
21.11.2024FDA Warns Chinese OTC Drug Manufacturer Following Review of Records